Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients-Reference-Cited by-同舟云学术

Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients

Published:2012-06-05 Issue:3 Volume:18 Page:510-516
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Frustaci Sergio,Buonadonna Angela,Turchet Elisa,Corona Giuseppe,Tabaro Gianna,Miolo GianMaria,Torrisi Elena,Lo Re Giovanni,Tumolo Salvatore,Toffoli Giuseppe

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-012-0410-z.pdf

Reference19 articles.

1. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354–362

2. Faivre J, Forman D, Estève J, Gatta G (1998) Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer 34:2167–2175

3. Murad AM, Santiago FF, Petroianu A et al (1993) Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 72:37–41

4. Pyrhönen S, Kuitunen T, Nyandoto P et al (1995) Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587–591

5. Glimelius B, Ekstrom K, Hoffman K et al (1997) Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8:163–168

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer;Frontiers in Oncology;2021-02-18

2. Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study);Cancers;2019-06-14

3. Combined Modality Treatment for Locally Advanced Gastric Cancer: Current Evidences and New Perspectives;Current Clinical Pathology;2019

4. New Agents in the Treatment of Advanced Gastric Cancer: Targeted Therapy and Immunotherapy;Current Clinical Pathology;2019

5. Trial Watch;OncoImmunology;2014-03